Lexaria Bioscience Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Lexaria Bioscience (LEXX), Evolus (EOLS) and Inspire Medical Systems (INSP)
Buy Rating on Lexaria Bioscience: Promising DehydraTECH Study and Market Potential
Maxim Group Remains a Buy on Lexaria Bioscience (LEXX)
Maxim Group Sticks to Their Buy Rating for Lexaria Bioscience (LEXX)
Maxim Group Initiates Coverage On Lexaria Bioscience With Buy Rating, Announces Price Target of $2
Lexaria Bioscience Analyst Ratings
Watching Lexaria Bioscience; Hearing Zacks Small-Cap Research Sets $15 Price Target
No Data